Movement Disorders (revue) - Analysis (USA)

Index « Auteurs » - entrée « Ely S. Simon »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Elvira Valera < Ely S. Simon < Emanuela Izzo  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000F60 (2006) Tanya Y. Gurevich [Israël] ; Herzel Shabtai [Israël] ; Amos D. Korczyn [Israël] ; Ely S. Simon [États-Unis] ; Nir Giladi [Israël]Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia
000F64 (2006) Shmuel Springer [Israël] ; Nir Giladi [Israël] ; Chava Peretz [Israël] ; Galit Yogev [Israël] ; Ely S. Simon [États-Unis] ; Jeffrey M. Hausdorff [Israël, États-Unis]Dual‐tasking effects on gait variability: The role of aging, falls, and executive function

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Aged
2Female
2Humans
2Male
2Nervous system diseases
1Accidental Falls
1Activities of Daily Living (classification)
1Adolescent
1Adult
1Age Factors
1Aged, 80 and over
1Antiparkinson Agents (adverse effects)
1Antiparkinson Agents (therapeutic use)
1Attention (physiology)
1Cholinesterase
1Cholinesterase Inhibitors (adverse effects)
1Cholinesterase Inhibitors (therapeutic use)
1Cognition Disorders (diagnosis)
1Cognition Disorders (physiopathology)
1Dementia
1Dementia (diagnosis)
1Dementia (drug therapy)
1Drug Therapy, Combination
1Executive function
1Functional Laterality
1Gait Disorders, Neurologic (diagnosis)
1Gait Disorders, Neurologic (physiopathology)
1Human
1Levodopa (adverse effects)
1Levodopa (therapeutic use)
1Memory (physiology)
1Mental Status Schedule
1Middle Aged
1Neurologic Examination
1Neurologic Examination (drug effects)
1Neuroprotective Agents (adverse effects)
1Neuroprotective Agents (therapeutic use)
1Neuropsychological Tests
1Parkinson Disease (diagnosis)
1Parkinson Disease (drug therapy)
1Parkinson disease
1Parkinson's disease
1Phenylcarbamates (adverse effects)
1Phenylcarbamates (therapeutic use)
1Postural Balance (physiology)
1Problem Solving (physiology)
1Reference Values
1Risk Factors
1Rivastigmine
1Senescence
1Statistics as Topic
1Tremor
1Tremor (chemically induced)
1Tremor (diagnosis)
1Tremor (drug therapy)
1Variability
1aging
1cholinesterase inhibitors
1cognitive functions
1dementia
1dual task
1executive function
1falls
1gait
1rivastigmine
1tremor

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/USA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i -k "Ely S. Simon" 
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/Author.i  \
                -Sk "Ely S. Simon" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/USA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    USA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Ely S. Simon
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024